Maintain a neutral, defensive low-turnover stance. Hold proven leaders and diversified defensive exposures, make no trade today, avoid adding to concentrated core positions or weak technology and AI-linked names, and retain the 26% cash reserve pending stronger breadth or clearer catalysts.
No trades this day. The fund held.
A directional call (beat or lag the S&P 500 over the horizon) on every researched name, whether or not the fund traded it. 34 calls (13 outperform, 21 underperform); 0 became trades. These are the fund's calibration record.
| Symbol | Call | Conf. | Why | |
|---|---|---|---|---|
| IREN | Underperform SPY | 87% | The 41.7% 30-day decline and adverse neocloud commentary make this a high-risk falling knife. | |
| CRWV | Underperform SPY | 82% | The 31.4% 30-day drawdown and neocloud-sector warnings indicate elevated downside and weak trend quality. | |
| APLD | Underperform SPY | 80% | The 28.4% 30-day decline and weak earnings-related backdrop make this an unfavorable risk-adjusted candidate. | |
| SNDK | Underperform SPY | 79% | The 28.2% 30-day decline and negative five-day momentum outweigh AI-infrastructure optimism. | |
| INTC | Underperform SPY | 78% | The 23.5% 30-day decline materially underperforms SPY and provides no confirmed reversal signal. | |
| CORZ | Underperform SPY | 77% | A 21.2% 30-day decline reflects persistent AI-infrastructure risk and poor relative momentum. | |
| BE | Underperform SPY | 76% | The 20.6% 30-day decline and negative-cash-flow concern leave the risk/reward unfavorable. | |
| META | Underperform SPY | 75% | The 16.7% 30-day decline and 11.1% five-day loss indicate pronounced negative momentum. | |
| GLW | Underperform SPY | 74% | An 18.2% 30-day decline combines with disclosed customer, demand, financing and execution risks. | |
| CAT | Underperform SPY | 72% | The 11.9% 30-day loss substantially trails SPY and there is no supplied evidence of stabilization. | |
| GOOGL | Underperform SPY | 69% | Negative five-day and 30-day momentum, a price below average cost and no confirmed near-term catalyst favor continued relative weakness. | |
| V | Outperform SPY | 69% | An 11.2% 30-day gain and strong embedded portfolio return demonstrate sustained payments-sector relative strength. | |
| MA | Outperform SPY | 68% | Its 9.1% 30-day gain materially exceeds SPY, reflecting strong payments-sector relative strength despite recent five-day softness. | |
| MU | Underperform SPY | 68% | Despite positive five-day performance, its 13.3% 30-day decline signals unresolved semiconductor weakness. | |
| XOM | Outperform SPY | 68% | Positive five-day momentum and an 11.6% 30-day gain show strong energy-sector relative strength. | |
| ORCL | Underperform SPY | 67% | A 9.4% 30-day decline meaningfully trails SPY despite modest recent five-day improvement. | |
| AMD | Underperform SPY | 66% | Its 30-day decline of 8.8% materially trails SPY and does not yet show a confirmed recovery. | |
| PG | Outperform SPY | 66% | Positive five-day momentum and an 8.7% 30-day gain support defensive relative strength. | |
| WMT | Outperform SPY | 65% | Positive five-day momentum and an 8.0% 30-day gain support defensive consumer leadership versus SPY. | |
| UNH | Outperform SPY | 64% | Its 10.5% 30-day gain materially exceeds SPY, supporting continued healthcare relative strength despite a weak recent week. | |
| ASML | Underperform SPY | 62% | A 6.1% 30-day decline and negative five-day momentum indicate weaker relative trends than SPY. | |
| MSFT | Outperform SPY | 62% | A 6.1% 30-day gain, substantial cushion above cost and earnings-related attention support relative strength, tempered by event risk. | |
| AAPL | Outperform SPY | 61% | Positive five-day and 30-day momentum, plus performance above cost, supports relative strength versus SPY despite concentration risk. | |
| QQQ | Underperform SPY | 59% | The 2.7% 30-day decline versus a modestly positive SPY reflects broad technology underperformance. | |
| AVGO | Underperform SPY | 58% | Recent five-day gains are constructive, but the stock remains down 3.6% over 30 days amid semiconductor-sector weakness. | |
| TSLA | Outperform SPY | 58% | Positive five-day and 30-day momentum support relative strength, although volatility makes the forecast lower confidence. | |
| NVDA | Underperform SPY | 57% | Semiconductor news is somewhat supportive, but negative five-day and 30-day returns still trail SPY. | |
| ^VIX | Outperform SPY | 57% | The VIX is up 15.4% over 30 days, indicating persistent demand for volatility protection relative to SPY. | |
| HD | Outperform SPY | 55% | Positive five-day and strong 30-day momentum suggest improving relative strength, though the position remains near cost. | |
| JNJ | Outperform SPY | 55% | Strong five-day momentum and defensive characteristics support relative resilience, although 30-day performance is essentially flat. | |
| TSM | Underperform SPY | 55% | Positive five-day momentum is insufficient to offset a negative 30-day trend and broader semiconductor softness. | |
| AMZN | Outperform SPY | 54% | Positive 30-day performance and an identifiable earnings focus support a modest relative-strength case, though five-day weakness limits conviction. | |
| JPM | Underperform SPY | 52% | Near-flat 30-day performance offers limited evidence of leadership versus SPY. | |
| SPY | Underperform SPY | 50% | As the benchmark itself, no meaningful relative-performance edge can be established; this is a neutral placeholder under the required binary field. |
Buy or hold: the portfolio has several clear relative-strength leaders and meaningful gains above cost, while the market backdrop remains constructive with the S&P 500 up 0.5% over 30 days and the Fed leaving rates steady. Leadership is concentrated in payments, consumer staples, healthcare, energy, and select technology rather than relying exclusively on speculative AI names. The evidence supports maintaining exposure and selectively adding to the strongest trends, while recognizing that elevated volatility and weakness in several mega-cap technology holdings argue against aggressive, broad-based buying.
The strongest bearish case is that portfolio momentum is deteriorating broadly while the S&P 500 is still up 0.5% over the past 30 days. Several technology, semiconductor, advertising, industrial, and AI-linked names are materially underperforming, and two holdings are already below cost. Adding to the weakest candidates would risk buying into accelerating drawdowns rather than confirmed recoveries.
The primary capital risk is concentration: despite 26.0% cash, the invested portfolio is heavily dependent on a few positions and sectors. AAPL, JNJ, and AMZN comprise 62.4% of invested assets, while Information Technology, Health Care, and Consumer Discretionary comprise 84.3%. Cash provides a material buffer, but does not remove the concentration of the 74.0% that is invested.
Cash is 26.0% of portfolio value and is intentional risk control rather than an uninvested oversight. It offsets concentration in AAPL, JNJ, AMZN and MSFT, preserves flexibility around earnings and elevated volatility, and avoids forcing capital into weak AI, semiconductor and cyclical momentum. Deployment should require either improving breadth or a clearly supported company-specific catalyst; neither is sufficiently established across the current opportunity set.
Accept: GOOGL is the clearest weak holding because it is below cost and down 5.1% over 30 days while SPY is modestly positive; there is no tool-supported catalyst sufficient to justify adding. Accept: META, ORCL, CAT, NVDA, AVGO and TSM demonstrate broad deterioration across growth, semiconductor and cyclical exposures, so new purchases in these names are not warranted. Accept: CAT's 11.9% 30-day decline lacks evidence of stabilization, making it a hold rather than an add. Partially accept: HD is slightly below cost, but its 30-day return is now positive and its five-day momentum is constructive; this supports monitoring and holding rather than treating it as equivalent to a sustained momentum failure. Accept: severely declining watchlist names including IREN, CRWV, APLD, SNDK, INTC, CORZ and BE are potential falling knives and should not be purchased. Accept: GLW's negative momentum and disclosed operational risks make it unsuitable for new capital. Accept: flat JNJ and JPM momentum, together with weakness in multiple technology holdings, limits the claim that portfolio strength is broad-based. Accept: technology and AI-linked holdings retain correlated downside risk. The bullish evidence is sufficient to retain strong existing leaders such as AAPL, MSFT, V, MA, XOM, PG, WMT and UNH, but not sufficient to justify broad buying or reduced liquidity.
The S&P 500 is modestly positive over 30 days (+0.5%) after the Fed held rates steady, but market breadth is uneven. Defensive, payments, energy and selected large-cap leaders show clear relative strength, while several technology, semiconductor, AI-infrastructure and cyclical names are weak. The VIX has risen 15.4% over 30 days, which supports a selective, low-turnover posture rather than broad risk addition.
The portfolio is profitable and retains substantial exposure to established leaders, including AAPL, JNJ, AMZN, MSFT, V and several defensive holdings. However, AAPL, JNJ, AMZN and MSFT dominate invested assets, while GOOGL remains below cost and several technology-linked positions have lagged SPY over 30 days. The appropriate action is to hold existing quality leaders, avoid increasing concentration, and avoid averaging into weak momentum.
The central risk is concentration, not insufficient equity exposure. AAPL is the largest holding, and AAPL, JNJ and AMZN represent a dominant share of invested capital; the four largest positions including MSFT account for roughly 71.7% of invested assets. Technology-linked exposure also remains correlated to AI spending, valuation compression and risk-off conditions. GOOGL, META, ORCL, CAT, NVDA, AVGO and TSM show varying degrees of negative 30-day momentum. The cash reserve mitigates total-portfolio drawdown but does not eliminate single-name or sector correlation risk within the invested sleeve.